Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions
The catechol-O-methyltransferase (COMT) enzyme metabolises catecholamines. COMT inhibitors are licensed for the adjunctive treatment of Parkinson's disease and are attractive therapeutic candidates for other neuropsychiatric conditions. COMT regulates dopamine levels in the prefrontal cortex (P...
Principais autores: | Laatikainen, L, Sharp, T, Harrison, P, Tunbridge, E |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Public Library of Science
2013
|
Registros relacionados
-
Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions.
por: Linda M Laatikainen, et al.
Publicado em: (2013-01-01) -
Catechol-o-methyltransferase (COMT) influences dopamine metabolism outside of the prefrontal cortex
por: Laatikainen, L, et al.
Publicado em: (2011) -
The Role of Catechol-O-Methyltransferase (COMT) in Modulating Hippocampal Dopaminergic Metabolism and Behaviour
por: Laatikainen, L, et al.
Publicado em: (2010) -
Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.
por: Laatikainen, L, et al.
Publicado em: (2012) -
Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders.
por: Harrison, P, et al.
Publicado em: (2008)